ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,841, issued on Nov. 11, was assigned to Nimbus Saturn Inc. (Boston).
"Substituted pyrrolo[3,4-cpyridines as HPK1 antagonists" was invented by Neelu Kaila (Lexington, Mass.), Ian Linney (Saffron Walden, Great Britain), Stuart Ward (Saffron Walden, Great Britain), Grant Wishart (Saffron Walden, Great Britain), Benjamin Whittaker (Saffron Walden, Great Britain), Alexandre Cote (West New York, N.J.), Jeremy Robert Greenwood (Brooklyn, N.Y.) and Abba Leffler (Bronx, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment...